Future Trends In Treating Liver Diseases

The routine screening of the blood donors for potentially transmissible infections has been reduced transfusion-associated infection whilst providing an insight into disease prevalence. This retrospective cross-sectional study evaluates the prevalence of the hepatitis B virus (HBV), hepatitis C virus (HCV) and, human immunodeficiency (HIV) and syphilis infection in 2,026,628 potential blood donors screened at Tehran Blood Transfusion Centre. One or the more transmissible infections were identified in 0.52% of the donors with greater prevalence in first time donors

  • Recent Advances in Liver Stem Cell Therapy
  • Hepatic Progenitors for Liver Disease
  • Which Stem Cells for Adult Liver?
  • The Role of Progenitor Cells in Repair of Liver Injury And In Liver Transplantation
  • Recent Advances in Pediatric Liver Transplantation

Related Conference of Future Trends In Treating Liver Diseases

November 13-14, 2017

Global Experts Meeting on Gastroenterology

Melbourne, Australia

Future Trends In Treating Liver Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in